Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,936 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Zhong CS, Beharry J, Salazar D, Smith K, Withington S, Campbell BCV, Wilson D, Le Heron C, Mason D, Duncan R, Reimers J, Mein-Smith F, Diprose WK, Barber PA, Ranta A, Fink JN, Wu TY. Zhong CS, et al. Among authors: mason d. Stroke. 2021 Mar;52(3):1087-1090. doi: 10.1161/STROKEAHA.120.030859. Epub 2021 Feb 16. Stroke. 2021. PMID: 33588597 Free article.
A Multi-Step Model of Parkinson's Disease Pathogenesis.
Le Heron C, MacAskill M, Mason D, Dalrymple-Alford J, Anderson T, Pitcher T, Myall D. Le Heron C, et al. Among authors: mason d. Mov Disord. 2021 Nov;36(11):2530-2538. doi: 10.1002/mds.28719. Epub 2021 Aug 10. Mov Disord. 2021. PMID: 34374460 Free PMC article.
The increasing prevalence of multiple sclerosis in New Zealand.
Alla S, Pearson J, Debernard L, Miller D, Mason D. Alla S, et al. Among authors: mason d. Neuroepidemiology. 2014;42(3):154-60. doi: 10.1159/000358174. Epub 2014 Feb 20. Neuroepidemiology. 2014. PMID: 24556851 Free article. Review.
Multiple Sclerosis impact on employment and income in New Zealand.
Pearson JF, Alla S, Clarke G, Mason DF, Anderson T, Richardson A, Miller DH, Sabel CE, Abernethy DA, Willoughby EW, Taylor BV. Pearson JF, et al. Among authors: mason df. Acta Neurol Scand. 2017 Sep;136(3):223-232. doi: 10.1111/ane.12714. Epub 2016 Nov 28. Acta Neurol Scand. 2017. PMID: 27891575
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand.
Bukhari W, Khalilidehkordi E, Mason DF, Barnett MH, Taylor BV, Fabis-Pedrini M, Kermode AG, Subramanian S, Waters P, Broadley SA; Australian and New Zealand NMO Collaboration. Bukhari W, et al. J Neurol. 2022 Feb;269(2):836-845. doi: 10.1007/s00415-021-10665-9. Epub 2021 Jul 2. J Neurol. 2022. PMID: 34213614
Multiple sclerosis in New Zealand.
Alla S, Mason DF. Alla S, et al. J Clin Neurosci. 2014 Aug;21(8):1288-91. doi: 10.1016/j.jocn.2013.09.009. Epub 2013 Nov 4. J Clin Neurosci. 2014. PMID: 24503208 Review.
2,936 results